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Abstract
Photodynamic therapy (PDT) has been developed as an anticancer treatment, which is based on the tumor-specific 
accumulation of a photosensitizer that induces cell death after irradiation of light with a specific wavelength. 
Depending on the subcellular localization of the photosensitizer, PDT could trigger various signal transduction 
cascades and induce cell death such as apoptosis, autophagy, and necrosis. In this study, we report that both AMP-
activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) signaling cascades are activated 
following 5-aminolevulinic acid (ALA)-mediated PDT in both PC12 and CL1-0 cells. Although the activities of caspase-9 
and -3 are elevated, the caspase inhibitor zVAD-fmk did not protect cells against ALA-PDT-induced cell death. Instead, 
autophagic cell death was found in PC12 and CL1-0 cells treated with ALA-PDT. Most importantly, we report here for 
the first time that it is the activation of AMPK, but not MAPKs that plays a crucial role in mediating autophagic cell death 
induced by ALA-PDT. This novel observation indicates that the AMPK pathway play an important role in ALA-PDT-
induced autophagy.
Introduction
Photodynamic therapy (PDT) has been developed as a
modality for cancer treatment which combines the use of
low energy light with the photosensitizer [1]. The rapid
tumor ablation by PDT involves direct cell killings as well
as damage to the exposed microvasculature [2]. Singlet
oxygen as well as other reactive oxygen species are the
major cytotoxic agents responsible for the PDT-induced
cellular damages [3]. Cellular and molecular mechanisms
involved in PDT-mediated oxidative stress are becoming
clear [4,5]. However, the signaling pathways involved in
the PDT-mediated cell death are not completely under-
stood.
5-aminolevulinic acid (ALA) itself is not a photosensi-
tizer and serves as the biological precursor in the heme
biosynthetic pathway. Exogenous ALA administration
leads to the accumulation of PpIX in the mitochondria,
which causes direct mitochondrial damage and subse-
quent cell death after light irradiation [6]. The integration
of a complex signaling network results in either cellular
repair/recovery or death. Activation of the three major
mitogen activated protein kinases (MAPKs), the extracel-
lular signal regulated kinase (ERK), c-Jun N-terminal
kinase (JNK), and the p38 kinase have been found in
PDT-treated cells [4,5]. Nevertheless, the roles of MAPKs
in mediating PDT-induced cell death depend on the cell
line and/or photosensitizer used.
AMP-activated protein kinase (AMPK) is a highly con-
served heterotrimeric serine/threonine protein kinase
that regulates energy homeostasis in mammalian cells
[7,8]. It can be activated by ATP depletion or AMP eleva-
tion [9]. The activated AMPK can restore energy homeo-
stasis inside cells by inhibiting anabolic reactions and
stimulating energy-producing catabolic pathways. Can-
cer cells exhibit characteristic metabolic demands that
are different from normal cells. Being a key metabolic
regulator, AMPK may regulate the switch. Other than a
metabolic sensor, AMPK also plays a critical role in
response to cellular stress such as hypoxia or oxidative
stress [10]. In addition, activation of AMPK has been
implicated in the regulation of anti-apoptotic [11-13] as
well as pro-apoptotic effects [14-16]. Recent studies also
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indicate the involvement of AMPK in autophagy induced
by stimuli such as hypoxia or nutrient-free medium [17-
19]. These observations imply that AMPK may be a
potential target for cancer treatment.
Autophagy is involved in removing damaged organ-
elles, a process that is required for the promotion of cellu-
lar survival during nutrient starvation, pathogen
infection, aging, and neurodegenerative processes
[20,21]. However, the constitutive activation of autophagy
can lead to cell death as a result of excessive self-destruc-
tion of cellular organelles [22]. PDT-treated cells can
undergo apoptotic or nonapoptotic pathways, depending
on the cell type, the photosensitizer, and the PDT dose
[5,23]. Recently, PDT-induced autophagy has also been
described [5,24]. However, the signaling molecule
involved in PDT-induced autophagy is not clear.
Previously, we have shown that ALA mediated PDT
could disrupt mitochondrial membrane potential, deplete
cellular ATP and hence, cause mitochondrial dysfunction
[25]. Since autophagy is a common response to mito-
chondrial dysfunction [26], we reasoned that ALA-PDT
may induce autophagic cell death by interfering with cel-
lular bioenergetics. In this study, we demonstrate that
ALA-PDT can trigger autophagic cell death by the regu-
lation of AMPK. Our results indicate that AMPK activa-
tion is required for ALA-PDT induced autophagic cell
death.
Results
Cell death induced by ALA-PDT involves the activation of 
AMP-activated protein kinase
The effect of ALA-PDT was first examined in the PC12
cell, a cell line derived from the pheochromocytoma cells
of the rat adrenal medulla [27]. ALA-PDT induced a sig-
nificant cytotoxicity in PC12 cells in a light-dose depen-
dent manner as indicated by the Trypan Blue exclusion
method (Fig. 1A, left panel). A sub-lethal dose of the light
(2 J/cm2) which led to ~60% cytotoxicity was chosen for
all the following experiments unless otherwise specified.
The cytotoxic effect of ALA-PDT could be effectively
blocked in a dose-dependent manner by the addition of
N-acetylcysteine (NAC), a known cell permeable antioxi-
dant (Fig. 1A, right panel). This suggests that the photo-
toxicity was caused by PDT-induced oxidative stress.
Similar results were also found in CL1-0 cells, a human
lung adenocarcinoma cell line [28] that is genetically dis-
tinct from PC12 cells (Fig. 1B). The mitochondrial integ-
rity was further examined because ALA-PDT induced
cytotoxicity has been related to mitochondrial damage in
several different cell lines [25,29,30]. As shown in Fig. 1C,
loss of mitochondrial transmembrane potential (Δψm)
was found in PC12 cells after ALA-PDT. Meanwhile, the
mitochondrial ATP content decreased 24% 30 minutes
after ALA-PDT, and further diminished by 77% 6 hours
after PDT (Fig. 1D). These results indicate that ALA-
PDT-induced cell death is related to mitochondrial pho-
todamage.
As depletion of ATP activates AMPK, we next exam-
ined the activity of AMPK following ALA-PDT. The
activity of AMPK was monitored with an antibody recog-
nizing the Thr172-phosphorylated AMPK. As shown in
Fig. 2A, a rapid elevation of the AMPK activity was found
in PC12 cells 30 minutes after light irradiation. Activation
of AMPK was also found in CL1-0 cells following ALA-
PDT under a light dose that reduced the CL1-0 cell sur-
vival by ~60% (12 J/cm2) (Fig. 2A). Meanwhile, pretreat-
ment with the specific inhibitor of AMPK (Compound C)
[31] rescued both PC12 and CL1-0 cells after ALA-PDT
(Fig. 2B). Together, these data indicate that the activation
of AMPK is involved in ALA-PDT-induced cell death.
ALA-PDT induces caspase-independent cell death
It has been largely documented that PDT-induced mito-
chondrial photodamage may trigger apoptosis, a caspase-
dependent cell death pathway [5,23,32]. Therefore, we
examined the characteristic indicator of apoptosis, the
DNA fragmentation pattern, following ALA-PDT. As
shown in Fig. 3A, oligonucleosomal DNA fragmentation
was detected as early as 6 hours post ALA-PDT in PC12
cells. It has been shown that apoptosis related to mito-
chondrial damage entails the activation of caspases-9 and
-3. We next examined the caspase-9 and -3 activities in
ALA-PDT-treated cells. As shown in Fig. 3B, optimal
activation of both caspase-9 (upper panel) and -3 (lower
panel) like protease activities were found to increase by
more than 5 fold 4 hours following ALA-PDT. Further-
more, the elevated caspase-like protease activity was
inhibited by a pan-apoptotic inhibitor, zVAD-fmk (Fig.
3C). Surprisingly, the irreversible inhibition of caspase
activation by zVAD-fmk did not protect PC12 cells from
ALA-PDT-induced cell death (Fig. 3D). Similar results
were also found in CL1-0 cells (data not shown). These
results indicate that ALA-PDT-induced cell death is inde-
pendent of caspase activation in both PC12 and CL1-0
cells.
Autophagy is the main cell death mode following ALA-PDT
Recently, induction of autophagic cell death has been
shown in PDT-treated cells [5,24]. To investigate if
autophagy is involved in PC12 cell death following ALA-
PDT, cells were incubated with monodansycadaverine
(MDC), a fluorescent marker for autophagosomes [33].
As shown in the fluorescence images in the upper panel
of Fig. 4A, increased MDC-positive autophagosomes
were found as early as 2 hours following ALA-PDT while
the control cells showed little MDC incorporation. LC3-
GFP, another autophagosome-localizing fusion protein,
has facilitated the study of autophagy in cancer cells [34].Ji et al. Molecular Cancer 2010, 9:91
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Figure 1 ALA-PDT-induced oxidative stress results in mitochondrial dysfunction and cell death. Survival rate of PC12 cells (A) and CL1-0 cells 
(B) after ALA-PDT. The right panel shows the cell survival rate of PC12 and CL1-0 cells which were incubated with 1 mM ALA for 3 hr, and then irradiated 
with different light dose. The left panel shows the survival rate of PC12 or CL1-0 cells pre-incubated with different concentrations of N-acetylcysteine 
(NAC) before ALA-PDT (1 mM ALA, 2 J/cm2 and 12 J/cm2 of light for PC12 and CL1-0 cells, respectively). Cell survival was assessed by Trypan Blue ex-
clusion assay 24 hours after light irradiation. Data were obtained from three independent experiments and are shown as mean ± SD. Significantly dif-
ferent from ALA only; *P < 0.05, **P < 0.01, ***P < 0.001. (C) Mitochondrial membrane potential decreased following ALA-PDT in PC12 cells. JC-1 
labeling of the cells treated with ALA only (left panel), right after (middle panel) or 30 minutes post light irradiation (right panel) under the light dose 
of 2 J/cm2 are shown. The upper panel represents the JC-1 monomer (green) and lower panel represents the JC-1 aggregate (red). (D) Following ALA-
PDT (1 mM ALA, 2 J/cm2), PC12 cells lysates were prepared at the indicated times and the ATP contents were measured using an ATP determination 
kit. The figure is a representative of three independent experiments and the results are shown as mean ± SD. Significantly different from ALA only; *P 
< 0.05, **P < 0.01.Ji et al. Molecular Cancer 2010, 9:91
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The transiently expressed LC3-GFP construct produces
diffuse fluorescence in the absence of autophagy and
punctuated signals in autophagosomes. In PC12 cells,
LC3-GFP began to aggregate in puncta in ALA-PDT-
treated cells as early as 2 hours after irradiation, while in
control cells the LC3-GFP signal was diffusely distributed
in the cytoplasm (Fig. 4A, lower panel).
During autophagy, the microtubule-associated protein-
1 light chain 3 (LC3) is processed from an 18 kDa LC3-I
form to a 16 kDa LC3-II form [35]. Therefore, increased
level of LC3-II is an additional characteristic of
autophagy due to its association with the autophagosome
membrane. To further assess the involvement of
autophagy after ALA-PDT, we performed immunoblot
analysis to detect the formation of LC3-II. Consistent
with the MDC staining and the punctuated LC3-GFP sig-
nals, elevated amounts of LC3-II were observed in ALA-
PDT-treated PC12 cells (Fig. 4B, left panel). The
increased LC3-II protein level was also found in the CL1-
0 cell line after ALA-PDT (Fig. 4B, right panel). More-
over, addition of the autophagy inhibitor, 3-methylade-
nine (3-MA), increased the PC12 cell survival rate in a
dose-dependent manner after ALA-PDT (Fig. 5A, left
panel). Similar results were also found in CL1-0 cells (Fig.
5B, left panel). Meanwhile, ALA-PDT-induced autophagy
contributed to a portion of the activation of caspase-9
and -3 as 3-MA could partially decrease the activation of
these caspases (right panels of Fig. 5A &5B). Taken
together, despite the possible co-existence of multiple cell
death fates, these results indicate that autophagy is the
major cell death pathway in PC12 and CL1-0 cells follow-
ing ALA-PDT.
Figure 2 ALA-PDT induced cell death is mediated through the activation of AMP-activated protein kinase. (A) Western blot analysis of phos-
phorylated AMPK (p-AMPK) expression in PC12 and CL1-0 cells treated with ALA-PDT under the light dose of 2 and 12 J/cm2, respectively. Equal 
amounts of protein (50 μg) from ALA-PDT-treated cells were loaded at each lane as confirmed by β-actin level. (B) Involvement of AMPK in the ALA-
PDT mediated cell death. PC12 (left panel) and CL1-0 (right panel) cells were incubated with 1 mM ALA for 3 hr in the presence of different concen-
tration of Compound C (AMPK inhibitor) for 30 min before light irradiation. Cellular cytotoxicity was determined using Trypan Blue exclusion assay. 
Values are expressed as a percentage relative to those obtained with cells without Compound C treatment. The figure is a representative of three 
independent experiments and the results are shown as mean ± SD. Significantly different from ALA only; *P < 0.05, **P < 0.01.Ji et al. Molecular Cancer 2010, 9:91
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Figure 3 ALA-PDT induces caspase-independent cell death. (A) PC12 cells were collected at various time points after ALA-PDT (1 mM ALA & 2 J/
cm2). DNA fragmentation was analyzed by agarose gel electrophoresis followed by ethidium bromide staining. (B) PC12 cell lysates were collected at 
various time points after ALA-PDT (1 mM ALA & 2 J/cm2). Caspase-9 (upper panel) and caspase-3 (lower panel) enzymatic activities were analyzed by 
using Caspase-3/CPP32 and Caspase-9 fluorometric assay kits, respectively. (C) After pre-incubation with the pan-apoptotic inhibitor, zVAD-fmk (40 
μM), cell lysates were collected at 4 hr post ALA-PDT. Caspase-9 and -3 activities were analyzed. Results are representative of three independent ex-
periments and shown as mean ± SD. (D) Cell survival after ALA-PDT is independent of zVAD-fmk dosage. Results are representative of three indepen-
dent experiments and shown as mean ± SD. No significant different from ALA-PDT only.Ji et al. Molecular Cancer 2010, 9:91
http://www.molecular-cancer.com/content/9/1/91
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AMPK, but not JNK nor p38, mediates autophagic cell death 
following ALA-PDT
We have demonstrated that the activation of AMPK was
associated with ALA-PDT-induced cell death (Fig. 2). To
investigate whether AMPK activation mediates ALA-
PDT-induced autophagic cell death, the expression level
of autophagic marker LC3-II was examined in the
absence or presence of Compound C. As shown in Fig.
5C, Compound C inhibited the formation of LC3-II in
both PC12 and CL1-0 cells treated with ALA-PDT, indi-
cating that ALA-PDT induced autophagic cell death is
mediated by AMPK.
Activations of JNK and p38 kinases have been reported
in human HaCaT keratinocytes and hypopharyngeal car-
cinoma FaDu cells treated with ALA-PDT [36,37]. In
agreement with previous findings, we found that ERK,
JNK, and p38 were activated in response to ALA-PDT
treatment, while the total level of these protein kinases
remained constant (Fig. 6A). The rapid activation of the
three MAPKs was found as early as 15 minutes after light
irradiation. Furthermore, JNK and p38 but not ERK
played a role in mediating ALA-PDT cytotoxicity because
JNK and p38 inhibitors significantly increased cell sur-
vival rate in ALA-PDT-treated PC12 cells (Fig. 6B).
As activation of MAPKs precedes the AMPK activa-
tion, we then examined whether MAPKs were involved in
the activation of AMPK by determining the level of phos-
phorylated AMPK in the presence of MAPK inhibitors.
As shown in Fig. 6C, blocking the three MAPK kinases
did not affect the AMPK activation, suggesting that the
elevated activity of AMPK is not related to MAPKs acti-
vation. Furthermore, the formation of LC3-II after ALA-
PDT was not interfered with by JNK and p38 inhibitors
(Fig. 6D), indicating that the ALA-PDT-induced
autophagic cell death was not a consequence of MAPKs
activation in PC12 and CL1-0 cells. Finally, treatment
with both AMPK and p38 inhibitors exhibited an additive
effect in preventing cell death as compared to the individ-
ual inhibitor alone in PC12 (Fig. 7A) and CL1-0 cells (Fig.
7B). This suggests that the activation of AMPK and p38
are two separated pathways stimulated by ALA-PDT.
Together, these data demonstrate for the first time that
Figure 4 ALA-PDT induces autophagic cell death in PC12 and CL1-0 cells. PC12 and CL1-0 cells were treated with 1 mM ALA for 3 hr, and then 
irradiated under the light dose of 2 and 12 J/cm2, respectively. (A) Autophagosome staining with MDC (upper panel) and expression pattern of trans-
fected LC3-GFP (lower panel) after ALA-PDT in PC12 cells. In ALA-PDT treated cells, MDC (0.05 mM) accumulated as a punctate pattern (arrows) pre-
dominantly in the cytoplasm beginning as early as 2 hr post ALA-PDT. Photomicrographs of MDC staining cells were taken at 200× magnification. LC3-
GFP (green), a known autophagosome marker, was expressed around the nuclear region. The nucleus was marked by Hoechst 33342 (blue). (B) Im-
munoblot analysis detected increased levels of the processed LC3-II in PC12 & CL1-0 cells treated with ALA-PDT, but not in cells treated with ALA only 
(control). β-actin was used as an internal control.Ji et al. Molecular Cancer 2010, 9:91
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t h e  a c t i v a t i o n  o f  A M P K  i s  m e d i t a t i n g  a u t o p h a g i c  c e l l
death in cells treated with ALA-PDT.
Discussion
The commitment events as well as the modality of cell
death induced by PDT have been extensively studied. It is
widely agreed that the action mechanism of PDT is
largely dependent on (1) the preferential subcellular
localization of the photosensitizer, (2) the molecular tar-
gets of the photosensitizer, and (3) the genotype of the
cell. Although caspase-dependent apoptosis has been
documented as the predominant cell death modality after
PDT [5,29,38-40], recent studies have also demonstrated
that PDT may induce non-apoptotic cytotoxicity via the
induction of autophagic cell death pathway [24,41]. In
this study, we observed that PC12 and CL1-0 cells under-
went autophagy after ALA-PDT as indicated by multiple
independent approaches that either revealed the forma-
tion of autophagic vacuoles or the expression of
autophagy specific proteins (Fig. 4). In addition, the cell
death was prevented by the autophagy inhibitor but not
the caspase antagonist (Fig. 5). These results led to our
conclusion that autophagy is the predominant form of
cell death in both PC12 and CL1-0 cells in response to
A L A - P D T .  H o w e v e r ,  i t  s h o u l d  b e  n o t e d  t h a t  t h e
autophagy inhibitor (3-MA) could not fully rescue the
ALA-PDT-induced cell death and also partially decreased
the activity of caspase-9 and -3 (Fig. 5A and 5B, right
panel). These observations might relate to the loss of
mitochondrial membrane potential (MMP) induced by
ALA-PDT . I t is possible that subsequent to the loss of
MMP, cytochrome c released from mitochondria might
still induce the activation of caspase-9 and caspase-3,
although caspase activation in this fashion did not play a
role in ALA-PDT mediated cell death. In addition, other
cell death regulators, such as apoptosis-inducing factor
(AIF) and the endonuclease G might be released from the
mitochondria as a result of MMP breakdown. These mol-
ecules could further lead to caspase-independent DNA
fragmentation [42], which explains the oligonucleosomal
DNA fragmentation induced by ALA-PDT (Fig. 3A). This
notion could be further supported by the findings of
Furre et al. [39] that showed that PpIX-mediated mito-
chondrion-photosensitization induces apoptosis through
translocation of AIF in human leukemia cells. In this
regard, we still cannot rule out the possibility that, other
than autophagy, ALA-PDT might induce other modes of
Figure 5 AMPK mediates autophagic cell death induced by ALA-
PDT. Effects of autophagy inhibitor, 3-MA, on ALA-PDT mediated cell 
death and caspase activity in PC12 (A) and CL1-0 (B) cells. PC12 and 
CL1-0 cells were pre-treated with different concentration of 3-MA be-
fore ALA-PDT. The light dose for PC12 and CL1-0 cells were 2 and 12 J/
cm2, respectively. Cell survival was analyzed 24 hr post ALA-PDT, and 
the caspase activity was analyzed 4 hr post ALA-PDT. (C) Expression 
level of LC-3 in PC12 and CL1-0 cells in response to Compound C treat-
ment. Cell lysates were collected at 8 hr post ALA-PDT for LC-3 western 
blot. β-actin was used as an internal control.
Figure 6 Activation of JNK and p38 involves in the ALA-PDT me-
diated cell death but not relates to the AMPK activation and au-
tophagic cell death. (A) PC12 and CL1-0 cells were treated with 1 mM 
ALA for 3 hr, and then irradiated under the light dose of 2 and 12 J/cm2, 
respectively. The cell lysates were collected at the time indicated after 
ALA-PDT. Kinase activity and protein level of the three MAPKs were an-
alyzed by western blot analysis with specific anti-phospho- or anti-
MAPK antibodies. β-actin was also used as an internal control. Repre-
sentative results from at least three independent experiments are 
shown. (B) PC12 cells were subjected ALA-PDT with or without the in-
hibitors of the three MAPKs. The blockers applied were PD98059 (ERK 
inhibitor, 40 μM), SP600125 (JNK inhibitor, 40 μM), and SB203580 (p38 
inhibitor, 40 μM). Cell survival was analyzed 24 hr post ALA-PDT. Signif-
icantly different from cells treated with ALA-PDT only; **P < 0.01. (C) 
PC12 cells were subjected ALA-PDT in the presence of the three MAPKs 
inhibitors. Cell lysates were collected 30 minutes post ALA-PDT (1 mM 
ALA, 2 J/cm2). AMPK activity was analyzed by western blot analysis us-
ing antibody recognized the p-AMPK. (D) In the presence of the inhib-
itor of JNK or p38, PC12 and CL1-0 cells were treated with 1 mM ALA 
for 3 hr, and then irradiated under the light dose of 2 and 12 J/cm2, re-
spectively. Cell lysates were collected at 8 hr post ALA-PDT and further 
used for LC-3 immunoblot analysis.Ji et al. Molecular Cancer 2010, 9:91
http://www.molecular-cancer.com/content/9/1/91
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caspase-independent cell death in PC12 and CL1-0 cells.
Further investigations are required to fully characterize
the concomitant mediators and determinant switches of
other minor types of cell death that might coexist in PC12
and CL1-0 cells in response to ALA-PDT.
Although PDT-induced stress-activated pathways
linked to cell death have been explored widely, direct bio-
chemical associations between the stress signals and cell
death, especially autophagy, remain poorly characterized.
Activation of the three MAPKs has been described in
various cell lines following PDT. However, the role of
A M P K  h a d  n o t  b e e n  r e p o r t e d  i n  P D T  b i o l o g y .  I n  a n
attempt to identify the major molecular event(s) required
for autophagic cell death induced by ALA-PDT, we evalu-
ated the activity of AMPK and MAPK protein kinase
families in PC12 and CL1-0 cells. We found that the acti-
vation of AMPK and JNK and p38 was one of the earliest
molecular events involved in the ALA-PDT-induced cell
death. Significant activation of JNK and p38 was found to
precede the activation of AMPK after ALA-PDT in both
PC12 and CL1-0 cell lines. Nevertheless, AMPK and
MAPK are independent effectors of ALA-PDT because
further studies showed that the level of AMPK activation
remained unaffected by the MAPK blockers (Fig. 6C).
Vice versa, inhibition of AMPK did not alter the activa-
tion level of MAPKs induced by ALA-PDT in PC12 and
CL1-0 cells (data not shown).
Although the activation of MAPK signaling could
induce autophagy [43], MAPKs are not involved in medi-
ating autophagic cell death in ALA-PDT treated cells
because the formation of autophagy specific LC3-II pro-
tein remained unaltered in response to the treatment of
JNK and p38 inhibitors (Fig. 6D). Conversely, the AMPK
inhibitor could effectively prevent the cell death after
ALA-PDT and could reduce the expression level of
autophagy-associated LC3-II protein. These results
together provide a novel yet intriguing link between
AMPK signaling cascade and autophagic cell death trig-
gered by ALA-PDT. Based on these results, we conclude
that autophagic cell death induced by ALA-PDT requires
the activation of AMPK but not MAPKs in both PC12
and CL1-0 cells. Although JNK and p38 are not involved
in the ALA-PDT-induced autophagic cell death (Fig. 6B),
it should be noted that the combination of AMPK and
p38 inhibitors has additive effect in increasing the cell
survival after ALA-PDT compared to the AMPK or p38
inhibitor alone (Fig. 7). Together, these data further dem-
onstrate that MAPKs and AMPK are independent path-
ways involved in ALA-PDT-induced cell death.
Our investigations reported in this article have revealed
the novel association of the activation of AMPK to ALA-
PDT-induced autophagic cell death. These findings shed
light on the development of new anticancer therapeutic
modality. However, the complex picture of multiple sig-
naling cascades that link PDT-induced oxidative stress to
the ultimate autophagic cell death remains far from com-
plete. Further characterization of the intermediating
mechanisms may reveal novel therapeutic strategy in
anti-cancer treatment.
Conclusion
In this study, we found that ALA-PDT effectively induced
oxidative stress that led to immediate mitochondrial dys-
Figure 7 Effects of the combined AMPK and MAPK inhibitors on 
PC12 and CL1-0 cell survival after ALA-PDT. In the presence of 
AMPK and MAPK inhibitors, PC12 and CL1-0 cells were treated with 1 
mM ALA for 3 hr and then irradiated under the light dose of 2 and 12 
J/cm2, respectively. Cell survival was analyzed by Trypan Blue exclusion 
assay 24 hr post ALA-PDT. Effects of AMPK (Compound C, 40 μM), JNK 
(SP600125, 40 μM) and p38 (SB203580, 40 μM) inhibitors on ALA-PDT 
induced cell death were analyzed in PC12 (A) and CL1-0 (B) cells. Re-
sults are representative of three independent experiments and are 
shown as mean ± SD. Significantly different from ALA-PDT with Com-
pound C, SP or SB; *P < 0.05, **P < 0.01.Ji et al. Molecular Cancer 2010, 9:91
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function, and finally resulted in a caspase-independent
cell death in PC12 and CL1-0 cells. In response to ALA-
PDT, activation of AMPK, JNK, and p38 signaling cas-
cades were found to promote cell death. However, it was
the activation of AMPK but not JNK or p38 that medi-
ated autophagic cell death in PC12 and CL1-0 cells.
These results indicate the involvement of AMPK and p38
pathways in this complex mechanism.
Materials and methods
Chemical reagents and antibodies
ALA, N-acetyl-L-cysteine (NAC), and monodansylcadav-
erine (MDC) and 3-methyladenine (3-MA) were pur-
chased from Sigma (St. Luis, MO, USA). 5,5',6,6'-
tetrachloro-1,1',3,3'- tetraethylbenzimida- zolylcarbocya-
nine iodide (JC-1) and ATP determination kit were pur-
chased from Molecular Probes (Eugene, OR, USA).
Lipofectamine 2000 transfection kit and Trypan Blue
were purchased from Invitrogen (Carlsbad, CA, USA).
Antibodies to phosphorylated ERK, p38, and AMPK or
total ERK, JNK and p38 were purchased from Cell Signal-
ing Technology (Danvers, MA, USA). Anti-phospho-JNK
antibody, Caspase-3/CPP32 and Caspase-9 fluorometric
assay kits were purchased from BioVision (Mountain
View, CA, USA). Monoclonal antibody that recognizes
both forms of LC3 was purchased from MBL Interna-
tional Cooperation (Woburn, MA, USA). PD98059 and
SB203580 were purchased from Promega. SP600125,
Compound C and zVAD-fmk (Z-Val-Ala-Asp(OMe)-flu-
oromethyl ketone) were obtained from Calbiochem (San
Diego, CA, USA).
Cell culture, transfection, and photodynamic treatment
PC-12 cells were incubated in DMEM supplemented with
5% fetal bovine serum (FBS) and 10% heat-inactivated
horse serum (HS). CL1-0 cells were derived from a poorly
differentiated human lung adenocarcinoma [28] and cul-
tured in RPMI medium containing 10% FBS. Cells were
cultured at 37°C in a humidified atmosphere containing
5% CO2. The GFP-LC3 transfected PC12 cells were pro-
duced by transfecting pGFP-LC3 plasmid into subconflu-
ent PC12 cells using Lipofectamine 2000 transfection kit.
For ALA-PDT, cells were seeded onto culture dishes or
chamber slides and grown overnight in complete
medium. Unless otherwise specified, cells were then
incubated with 1 mM ALA for 3 hr, and then exposed to
various doses of light. The light source is consisted of
high power LED array, with the wavelength centered at
635 ± 5 nm [25]. The light dose is 1-6 J/cm2 (PC12) or 12
J/cm2 (CL1-0) at an intensity of 60 mW/cm2. After irradi-
ation, cells were incubated in complete medium until fur-
ther analyzed.
Cell survival rate
After ALA-PDT, cellular cytotoxicity was determined by
T r y p a n  B l u e  e x c l u s i o n  a s s a y .  B r i e f l y ,  c e l l s  w e r e
trypsinized 24 hr post ALA-PDT and co-incubated with
0.4% (w/v) Trypan Blue at room temperature for 10 min.
Cells with Trypan blue uptake were counted as dead cells
on a hemacytometer. Cells exposed to ALA without light
irradiation were used as controls. Each individual photo-
toxic experiment was repeated for three times.
Analysis of mitochondrial membrane potential
Prior to examine the mitochondrial membrane potential,
cells were seeded into chamber slides and allow growing
for 24 hr. On the next day, cells were incubated with 1
mM ALA for 3 hr. For the last 20 min of ALA incubation,
cells were stained with 10 μg/ml of JC-1 for the examina-
tion of mitochondrial membrane potential. After light
irradiation, JC-1 staining patterns were visualized with
the confocal spectral microscope (Leica, model TCS
SP2). JC-1 was excited by a 488 nm agron-ion laser and
the emitted fluorescence was measured at 525 ± 20 nm
for JC-1 monomers and 615 ± 25 nm for JC-1 aggregates.
All experiments were performed under ambient light.
Determination of mitochondrial ATP content
Mitochondrial ATP content was measured with an ATP
determination kit according to manufacturer's instruc-
tions (Molecular Probes, Eugene, OR, USA). Briefly, cells
were plated and incubated in glucose-free culture
medium for 3 hr to avoid the production of ATP via glyc-
olysis. At the time indicated after ALA-PDT, cells were
lysed with 1% Triton and mixed with ATP reaction buffer
before measuring the luminescence by a luminescence
counter. The relative luminescence intensities were cor-
rected with the amount of total protein in the cell extract.
Three measurements were taken from each sample for
statistical analysis.
Assays of DNA fragmentation and caspase enzymatic 
activity
For DNA fragmentation analysis, PC12 cells were
returned to the complete medium after ALA-PDT and
cell pellets were collected at the time indicated. DNA
from the cell pellets was isolated with QIAamp DNA
Mini kit according to the manufacturer's instructions
(Qiagen, Valencia, CA, USA) before further analyzed in a
1.5% agarose gel. After electrophoresis, the gel was
stained with 0.5 μg/ml ethidium bromide and photo-
graphed under UV light. For caspase activity, PC12 &
CL1-0 cells were seeded into Petri-dishes. After ALA-
PDT, cells were returned to the complete medium and
cell lysates were collected at the time indicated to deter-
mine the caspase-9 and -3 like activities by the assay kit
used according to manufacturer's instructions.Ji et al. Molecular Cancer 2010, 9:91
http://www.molecular-cancer.com/content/9/1/91
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Fluorescence imaging of MDC and GFP-LC3
PC12 or GFP-LC3 transfected PC12 cells were seeded
into Chamber Slides and incubated for 24 hr. On the next
day, cells were treated with ALA-PDT. At the time indi-
cated, PC12 cells were stained with 0.05 mM MDC in
PBS for the imaging of autophagosomes. To detect the re-
distribution of GFP-LC3 after ALA-PDT, GFP-LC3 trans-
fected PC12 cells were fixed and co-stained with Hoechst
33342 to label the nucleus. Cells were then washed with
PBS and immediately observed under microscope. The
MDC fluorescence images were taken under Zeiss Axio-
phot 2 Fluorescence Microscope. The fluorescence pho-
tographs of LC3-GFP were recorded upon excitation by a
488 nm agron-ion laser and the emission measured at 525
± 25 nm using the confocal fluorescence microscope
(Leica TCS SP5). A Diode UV laser (405 nm) was used to
excite Hoechst 33342 and the emitted fluorescence was
collected at 445 ± 15 nm.
Immunoblot analysis
Cells treated with ALA-PDT were lysed at the time indi-
cated. Equal amount of protein lysates were electrophore-
sed on 10% SDS-polyacrylamide gels. The proteins were
transferred to the nitrocellulose membrane and incu-
bated with antibodies recognizing both form of LC-3,
phosphorylated form of ERKs, JNK, p38, AMPK proteins
or β-actin (as loading control). We also determined the
total amount of ERK, JNK and P38 using antibodies spe-
cific to all forms of ERK, JNK and p38, respectively. Sec-
ondary antibody conjugated with horseradish peroxidase
was applied and immunocomplex was visualized by
Chemiluminescence Reagent Plus (Blossom Biotechnol-
ogy Inc., Boston, USA).
Statistical analysis
All experiments were repeated at least three times with
4~6 parallel measurements in different dishes or slides.
Results were averaged from experiments performed
under the same conditions and described as the mean ±
SD unless stated otherwise. The statistical significance of
differences in the results was analyzed using Student's t-
test for paired experiment or one-way ANOV A test for
multiple comparisons.
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